Simon Bonouvrie

At Cadence, we have a process of scaling into and out of stock positions. When a price trend in a stock turns and moves materially off a previous high we will start selling the position. This process of scaling out of the position continues as the stock trends lower. We... Show More

Simon Bonouvrie

Gilead Sciences (NASDAQ: GILD) was the first offshore position in the Cadence portfolio, initiated in mid-2014. We initiated the position at a price of approx US$82 and have added to the stock since then. The stock is currently US$122. Gilead is a large US biotech stock specialising in antiviral drugs... Show More

No comments.